Por: ABC News Health December 30, 2022
WASHINGTON -- The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.”The 18-month investigation by two House committees detailed “atypical collaboration” between FDA regulators and a company it’s supposed to oversee -- Aduhelm manufacturer Biogen. The probe also cited Biogen documents saying the... + full article
ABC7 USA Health January 07, 2023
WASHINGTON -- U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.The drug, Leqembi, is the first... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
Here's what disease does to brain, signs to look for: Alzheimer's Q&A | The Advocate
CNBC USA Health January 06, 2023
In this articleMRI image of brain showing area of Alzheimer patient.Getty ImagesThe Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from and its Japanese partner Eisai to receive an early green... + más
FDA Approves Alzheimer's Drug That Slowed Cognitive Decline in Clinical Trial | NBC 6 South Florida
NBC 6 South Florida USA World January 06, 2023
Getty Images MRI image of brain showing area of Alzheimer patient. data-ellipsis=false> The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from and its Japanese partner Eisai to receive an early... + más
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial | CNBC
The Advocate USA Health January 02, 2023
What is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
Los Angeles Times USA Science December 30, 2022
The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed “atypical... + más
Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News
Probe: Alzheimer's drug approval 'rife with irregularities' | WPLG Local 10
CNBC USA Health November 30, 2022
Alzheimer's is the most common form of dementia, a general term for loss of memory, language, and other thinking abilitiesBrian B. Bettencourt Toronto Star Getty ImagesA trial of an experimental Alzheimer's drug has been hailed as a new era in the beleaguered fight to... + más
Experimental drug appears to slow progression of Alzheimer's disease but raises safety concerns | ABC7
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
About iurex | Privacy Policy | Disclaimer |